TG Therapeutics | TGTX - 보통주 자본





보통주 자본 변화 날짜
AbbVie USD 1.77B 1.75B 2025-06
Alaunos Therapeutics USD 2.38M 172K 2026-03
Amgen USD 540M 1000K 2026-03
Ardelyx USD 246.97M 2.62M 2026-03
Arrowhead Research USD 137.39M 1.69M 2025-12
Bayer EUR 982.42M 0 2025-12
Biogen USD 146.7M 200K 2025-09
Corcept Therapeutics USD 107.33M 1.36M 2026-03
Curis USD 12.93M 12.87M 2025-12
Gilead Sciences USD 1.24B 1000K 2026-03
J&J USD 2.41B 1.35M 2026-03
Karyopharm Therapeutics USD 18.31M 18.3M 2025-12
Novartis USD 1.9B 7.38M 2026-06
Novavax USD 162.58M 106K 2025-12
PTC Therapeutics USD 82.88M 1.41M 2026-03
Puma Biotechnology USD 5K 0 2024-06
Regeneron Pharmaceuticals USD 105M 300K 2026-03
Roche Holding CHF 796.77M 1.15M 2026-06
TG Therapeutics USD 155.31M 95K 2025-12
Verastem USD 77.74M 77.74M 2025-12
Vertex Pharmaceuticals USD 254.2M 200K 2026-03